Effectiveness of deep dry needling in active miofascial trigger points in the reduction of non-specific cervical pain

ISRCTN ISRCTN22726482
DOI https://doi.org/10.1186/ISRCTN22726482
Secondary identifying numbers 26/2010
Submission date
09/10/2011
Registration date
08/11/2011
Last edited
18/01/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Miofascial pain syndrome is another way to describe muscle pain. A lot of people have trigger points on their shoulder area that cause pain and tightness when stressed or injured. Physical therapy treatment of trigger points can be either conservative or invasive. They are usually treated by massages. Another more invasive option is known as dry needling. This is when needles are placed into the skin around one cm deep to penetrate the trigger point. Recent research has shown that deep dry needling of trigger points can improves pain pressure threshold (PPT) and joint ranges of motion (ROM) of the treated area. The aim of this study is to know if deep dry needling of myofascial trigger points of cervical (neck) muscles is effective in helping pain of these points in patients with non specific cervical pain.

Who can participate?
Adults aged 18 and older who are suffering from neck pain in the last three months.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group receive invasive physical therapy and have deep dry needling in certain trigger points and stretching of the muscles after the dry needling. Those in the second group receive the stretching but not the dry needling. All participants receive two sessions a week over two years. There are assessed for pain levels and have follow up physical therapy sessions after the treatment.

What are the possible benefits and risks of participating?
Participants may benefit from improvements with their physical health and a reduction in pain. There is a risk of pain that can develop over 48 hours after the treatment.

Where is the study run from?
University of Alcalá (Spain)

When is the study starting and how long is it expected to run for?
June 2011 to December 2013

Who is funding the study?
Carlos III National Health Care Institute (Spain)

Who is the main contact?
Professor Ester Cerezo-Téllez

Contact information

Prof Ester Cerezo-Téllez
Scientific

University of Alcalá
Faculty of Nursing and Physiotherapy
Madrid
E-28871
Spain

Study information

Study designSimple blinded randomized controlled clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleEffectiveness of deep dry needling in active miofascial trigger points in the reduction of non-specific cervical pain
Study objectivesDeep dry needling of miofascial active trigger points of cervical muscles in patients suffering frominespecific cervicalgya is effective in patient's pain dimminution.

The prevalence of Miofascial active trigger points and non-specific cervicalgia are related.
Ethics approval(s)1. Ethics Committee of Clinical Trials of Area 3 at University Hospital of Alcalá de Henares, Madrid (Spain), July 2010, ref: 26/2010
2. Research Central Comission of Ethics of "Gerencia Area 3 Atención Primaria", 13 April 2011, ref: 44/11
Health condition(s) or problem(s) studiedPain
InterventionPatients in the group of "Invasive Physical Therapy" will be treated with deep dry needling in all miofascial active trigger points found in cervical musculature described. They were also be applied analytical passive stretching of the muscles where deep dry needling have been applied.

Patients in "control group" (minimal intervention group) will receive the same analytical passive stretching in the muscles where active MTrPs have been found than patients in the group of "Invasive Physical Therapy." In both groups, the intervention program will consist of 2 sessions a week over a period of 2 weeks, 4 sessions of physiotherapy in total. There will be a physiotherapy review pre-intervention as baseline, a second assessment physiotherapy during the intervention (after the 2nd session of treatment) and third assessment of physical therapy after finishing the intervention (at the end of the 4th session of physical therapy), and 4 ratings physiotherapeutic track 15, 30, 90 and 180 days.
In the event that the patient no longer reported pain (VAS = 0) before the end of the scheduled physical therapy sessions, physical therapy should be stopped keeping follow-up assessments provided.

Follow-up
After first baseline assessment pre-intervention assessments were scheduled during physical therapy.

Reviews post-intervention (4 days after physical therapy treatment so that post-needling pain does not influence the assessment):
1. After physical therapy treatments and before the third session of physical therapy
2. After the fourth physical therapy treatment
3. Assesments during the treatment
4. Physical therapy evalutations were conducted as follow-up at 15, 30, 90 and 180 days respectively.

Each group will be treated by a different physiotherapist. Before starting the study, consensus intervention meetings will be held to ensure that analytical passive stretching of the muscles in both groups is identical. All physical therapy participants in the study are specialists in physical therapy diagnosis and the Miofascial pain syndrome.
Intervention typeOther
Primary outcome measureSubjective pain using Visual Analogue Scale (VAS)
Secondary outcome measures1. Demographic
2. Antropometrics: weight and height
3. Antecedents: evolution time of the problem, previous traumatisms, etc.
4. Assesment of muscles (trapezius, levator scapulae, multifidus, esplenius cervicis) to find presence of Miofascial Active trigger points
5. Pain pressure threshold of active MTrP in mentioned musculature using algometry Foix (Wagner Intruments, USA) in Kg/cm2
6. Cervical articular range of movement (Flexoextension, rotation and lateral flexion (inclination)) using CROM goniometer in degrees
7. Strength (Flexion, extension, rotation and lateral flexion (inclination)) using digital dinamometer Microfet 2 (Hoogan Health Industries, USA) in Newtons
8. If patients have any analgesics (Non steroideal anti-inflamatory drugs)
Overall study start date01/06/2011
Completion date30/12/2013

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants148 patients will be selected
Key inclusion criteria1. Over 18 years old
2. Present a diagnostic of non specific cervical chronic (more than 3 months with pain sintomatology)
3. Neck pain (with non-traumatic antecedents, neurologic infection, discal problems)
4. Present Miofascial active Trigger Points in multifidus, splenius cervicis, levator scapulae and trapezius muscles
5. The pain must be on or over 3 points in Visual Analogue Scale
6. The patients must have signed the informed consent
Key exclusion criteria1. Patients who present any contraindication for physical therapy treatment as deep dry needling (infection, fever, hypothyroidism, insuperable afraid of needles, injuries on the skin above the needling, metal allergy, cancer, systemic diseases)
2. Psycotic and depresive patients
Date of first enrolment01/06/2011
Date of final enrolment30/12/2013

Locations

Countries of recruitment

  • Spain

Study participating centre

University of Alcalá
Madrid
E-28871
Spain

Sponsor information

University of Alcalá, Madrid (Spain)
University/education

c/o Prof Ester Cerezo-Téllez
Faculty of Physiotherapy
Madrid
E-28871
Spain

Website http://www.uah.es/
ROR logo "ROR" https://ror.org/04pmn0e78

Funders

Funder type

Hospital/treatment centre

Carlos III National Health Care Institute (Spain)

No information available

Mapfre Foundation (Spain)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Mapfre Foundation
Location
Argentina
Investigator initiated and funded

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/09/2016 18/01/2019 Yes No

Editorial Notes

18/01/2019: Publication reference added
23/06/2017: Plain English summary added.